Abbott has delivered new, longer-term data from a clinical study of its dissolving stent for severe peripheral artery disease ...

Heart disease is expected to affect 61% of US adults by 2050, so it’s important to know when problems may be afoot.

Following a greenlight from the US FDA, Philips has enrolled the first patient in a trial of its newest intravascular ...

Learn about Peripheral Artery Disease (PAD) and its impact on the Black community. Discover the risks, symptoms, and treatment options for this irreversible medical condition.

With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a ...

Gains from its Bitcoin holdings contributed notably to EPS growth. Semler Scientific produces the QuantaFlo -- a non-invasive ...

Johnson & Johnson MedTech's Shockwave Medical unit today announced the first clinical outcomes associated with its Javelin ...

Royal Philips announced enrollment of the first patient in THOR, a United States investigational device exemption (IDE) clinica ...

What is Peripheral Vascular Disease? Symptoms and Causes Explained - Peripheral Vascular Disease, PVD for short, is a ...

They also looked at the MSK-Frailty Index, a composite measure of the following clinical risk factors: chronic obstructive ...

Coronary artery disease is the silent killer because you can have it for years and have no symptoms until it’s too late.